Gidazepam and its Energetic metabolite desalkygidazepam are benzodiazepines that may soon develop into drugs of abuse.This could bring about the incorrect interpretation of the Bogus positive immunoassay-based BZD end result. A study in Sweden found that 40% of presumably Wrong-constructive BZD outcomes basically contained a non-accredited BZD (For